A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 3.27 EUR 2.19% Market Closed
Market Cap: 248.3m EUR
Have any thoughts about
Atrys Health SA?
Write Note

Atrys Health SA
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atrys Health SA
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
A
Atrys Health SA
MAD:ATRY
Long-Term Investments
€6.2m
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Atrys Health SA
Glance View

Market Cap
248.3m EUR
Industry
Health Care

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

ATRY Intrinsic Value
5.33 EUR
Undervaluation 39%
Intrinsic Value
Price
A

See Also

What is Atrys Health SA's Long-Term Investments?
Long-Term Investments
6.2m EUR

Based on the financial report for Jun 30, 2024, Atrys Health SA's Long-Term Investments amounts to 6.2m EUR.

What is Atrys Health SA's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
10%

Over the last year, the Long-Term Investments growth was -13%. The average annual Long-Term Investments growth rates for Atrys Health SA have been 7% over the past three years , 10% over the past five years .

Back to Top